Related Experiment Video
Updated: Nov 20, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Modeling autosomal dominant Alzheimer's disease with machine learning
Patrick H Luckett1, Austin McCullough1, Brian A Gordon1
1Washington University in St. Louis, St. Louis, Missouri, USA.
Machine learning models revealed distinct disease progression patterns in autosomal dominant Alzheimer's disease. These models accurately predict future changes in amyloid, metabolism, and brain volume, aiding in understanding disease trajectories.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Genetics
Background:
- Autosomal dominant Alzheimer's disease (ADAD) represents a unique genetic model for studying Alzheimer's disease (AD) pathogenesis.
- Understanding the precise trajectories of molecular and structural changes in ADAD is crucial for developing targeted interventions.
Purpose of the Study:
- To apply machine learning models for discovering novel disease trajectories in ADAD.
- To identify key predictors of disease progression across multiple imaging modalities.
Main Methods:
- Longitudinal structural MRI, amyloid PET, and fluorodeoxyglucose PET data were collected from 131 ADAD mutation carriers and 74 non-carriers.
- A deep neural network was trained to predict disease progression, and Relief algorithms identified significant predictors.
- The study utilized data from the Dominantly Inherited Alzheimer Network (DIAN).
Main Results:
- The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors of mutation status.
- The predictive model achieved high accuracy (R² = 0.95 for Pittsburgh compound B and atrophy, R² = 0.93 for fluorodeoxyglucose) in forecasting future changes.
- Disease progression was characterized by sigmoidal amyloid accumulation, biphasic metabolic changes, and gradual volume decrease.
Conclusions:
- Machine learning effectively models ADAD progression, revealing distinct sigmoidal and biphasic trajectories for key biomarkers.
- The findings highlight specific brain regions (subcortical, middle frontal, posterior parietal) most affected during disease progression.
- This approach offers a powerful tool for understanding ADAD and potentially other neurodegenerative diseases.
More Related Videos
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment